Page last updated: 2024-12-06

letrazuril

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Letrazuril is a synthetic anticoccidial drug used to treat coccidiosis in animals, particularly in poultry and cattle. It acts by inhibiting the growth and development of coccidia parasites, which are protozoa that cause intestinal infections and can lead to significant economic losses in livestock production. Letrazuril is effective against a wide range of coccidia species, including Eimeria spp. in poultry and cattle. Its mechanism of action involves interfering with the parasite's mitochondrial electron transport chain, leading to energy depletion and ultimately parasite death. Letrazuril is typically administered orally in feed or water, and it has a long duration of action, providing protection against coccidiosis for several weeks. The drug has been shown to be safe and effective in numerous studies, and it is widely used in the livestock industry. Letrazuril's effectiveness, safety, and wide spectrum of activity have made it a valuable tool for preventing and controlling coccidiosis in animals. It has contributed to improved animal health, reduced economic losses, and enhanced food production.'
```

letrazuril: effective against Cryptosporidium infections [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID59745
CHEMBL ID2104819
SCHEMBL ID466345
MeSH IDM0215577

Synonyms (26)

Synonym
letrazuril [inn]
2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]-2-(4-fluorophenyl)acetonitrile
[2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3h)-yl)phenyl](4-fluorophenyl)acetonitrile
CHEMBL2104819
(+-)-(2,6-dichloro-4-(4,5-dihydro-3,5-dioxo-as-triazin-2(3h)-yl)phenyl)(p-fluorophenyl)acetonitrile
u8736vcb22 ,
letrazurilo [inn-spanish]
letrazurilum [inn-latin]
unii-u8736vcb22
letrazurilo
letrazuril
103337-74-2
letrazurilum
(+/-)-(2,6-dichloro-4-(4,5-dihydro-3,5-dioxo-as-triazin-2(3h)-yl)phenyl)(p-fluorophenyl)acetonitrile
letrazuril [mart.]
SCHEMBL466345
CS-7795
c17h9cl2fn4o2
HY-106859
DB12663
DTXSID60869392
2-(2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3h)-yl)phenyl)-2-(4-fluorophenyl)acetonitrile
W18799
Q27290829
AS-56245
AKOS037645026
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (33.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (50.00%)4.05%
Observational0 (0.00%)0.25%
Other1 (16.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]